Adam L. Cohen, M.D., has joined the Internal Medicine leadership team as the department’s Clinical Research Medical Director. Dr. Cohen’s appointment to this position is the culmination of a process initiated by Dr. John Hoidal to increase compliance support to the department’s clinical research community. Dr. Cohen will work with department leaders to identify and prioritize key compliance requirements and process improvements. He will serve as a resource to faculty on such topics as investigator-initiated trials, sponsor audits, and clinical research best practices, and will be aligned with the IM Research Administration office. Dr. Cohen is an Assistant Professor in the Oncology Division and received his medical degree from Harvard Medical School. He is a member of the HCI Experimental Therapeutics program. Specialties are neuro-oncology, breast oncology and gynecologic cancers, with a focus on clinical trials and pharmacogenomics. Dr. Cohen co-chairs HCI’s Protocol Review and Monitoring Committee, which reviews cancer-related research projects for scientific merit and progress in compliance with NCI guidelines.